Eli Lilly and Company
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2013
Total Assets: $35.25B
Liabilities Breakdown FY2013
Total Liabilities: $17.62B
Asset Breakdown
Total Assets: $35.25B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.83B | 10.9% |
| Accounts Receivable | $3.43B | 9.7% |
| Inventory | $2.93B | 8.3% |
| Property, Plant & Equipment | $7.98B | 22.6% |
| Goodwill | $1.52B | 4.3% |
| Intangible Assets | $2.81B | 8.0% |
| Other Assets | $12.75B | 36.2% |
Liabilities Breakdown
Total Liabilities: $17.62B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.12B | 6.4% |
| Long-Term Debt | $4.20B | 23.8% |
| Other Liabilities | $12.30B | 69.8% |